Haemonetics Corp. (HAE) Misses Q2 EPS Views; Affirms Outlook
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $75.07 +0.29%
EPS Growth %: -0.9%
Financial Fact:
Net income: 0.39
Today's EPS Names:
CRMT, More
EPS Growth %: -0.9%
Financial Fact:
Net income: 0.39
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.65, $0.13 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $170.6 million versus the consensus estimate of $170.4 million.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Creative Medical Technology issues mid-year pipeline update
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
